35298 Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices 

partners across state health departments 

and collaborating divisions within CDC. 

The information collection and 

reporting requirements have been 

carefully designed to align with, and 

support the specific goals and outcomes 

outlined in the Core SIPP cooperative 

agreement. The overarching goal of Core 

SIPP is to strengthen the awardee’s 

injury prevention programs and policies 

and demonstrate impact in the 

reduction of injury-related morbidity 

and mortality. Although the data are 

limited to the 23 recipients of the Core 

SIPP NOFO, the results can be 

generalizable and inform injury 

prevention work. Moreover, it is 

asserted that the results of the data 

collection are vital to ensuring the Core 

SIPPs efficient management. Results 

will not only allow NCIPC staff to 

provide data-driven technical assistance 

to recipients, but also to assess patterns 

across other NCIPC injury prevention 

programs such as, Prescription Drug 

Overdose Prevention for States and the 

Injury Control Research Centers. In 

addition, the data collection will inform 

the continuous quality improvement 

process and allow NCIPC staff to make 

mid-course corrections and describe the 

impact on health outcomes. 

The information collection 

procedures will also allow NCIPC to 

respond to inquiries from the HHS, the 

White House, Congress and other 

stakeholders about program activities 

and their impact; as well as, work 

towards CDCs overarching mission to 

protect America from health, safety and 

security threats, both foreign and in the 

U.S. NCIPC will use the information 

collected in the Partners’ Portal to 

perform program activities to 

accomplish the following objectives: 

• Monitor each awardee’s progress 

and identify facilitators and barriers to 

program implementation and 

achievement of outcomes. Monitoring 

allows NCIPC to determine whether an 

awardee is meeting performance goals, 

to inform awardee continuous quality 

improvements, and to inform the type of 

intensity of CDC-provided technical 

assistance to support attainment of their 

performance measures. 

• Identify trends in injury 

surveillance data to inform state foci for 

prevention and intervention strategies 

as well as the production of relevant 

reports, journal articles, and resources 

for state health departments. 

• Identify, translate, and disseminate 

information about successful injury 

prevention and control strategies 

implemented by recipients through the 

development of journal articles, tools, 

templates, and other injury prevention 

resources/products. 

Program recipients will use the 

information collected to manage and 

coordinate their activities and to 

improve their efforts to prevent and 

control injuries. The Partners’ Portal 

allows recipients to fulfill their annual 

reporting obligations efficiently by 

employing user-friendly, easily 

accessible web-based instruments to 

collect necessary information for both 

progress reports and continuation 

applications including work plans. This 

approach enables recipients to save 

pertinent information from one 

reporting period to the next and reduces 

the administrative burden on the annual 

continuation application and the 

performance monitoring process. 

Awardee program staff are able to 

review the completeness of data needed 

to generate required reports, enter basic 

summary data for reports annually, and 

finalize and save required reports for 

upload into other reporting systems as 

required. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Core SIPP Program Recipients ........ Annual Progress Report ................... 23 1 11 253 

Total ........................................... ........................................................... ........................ ........................ ........................ 253 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–14224 Filed 7–1–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Agency for Toxic Substances and 

Disease Registry 

Center for State, Tribal, Local, and 

Territorial Support (CSTLTS), CDC/ 

ATSDR Tribal Consultation Session 

AGENCY: Centers for Disease Control and 

Prevention (CDC)/Agency for Toxic 

Substances and Disease Registry 

(ATSDR), Department of Health and 

Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC)/Agency 

for Toxic Substances and Disease 

Registry (ATSDR), announces the 2021 

CDC/ATSDR Tribal Consultation 

Session. CDC/ATSDR will host 

American Indian and Alaska Native (AI/ 

AN) Federally Recognized Tribes for the 

virtual tribal consultation session. The 

proceedings will be open to the public. 

DATES: The tribal consultation will be 

held on August 5, 2021, from 3:15 p.m. 

to 5:00 p.m., EDT. Written tribal 

testimony is due by 5:00 p.m., EDT, on 

September 7, 2021. 

ADDRESSES: Zoom Virtual Tribal 

Consultation. To register, see CDC web 

page https://cdc.zoomgov.com/meeting/ 

register/vJIsfu-gqDgsGD1rTre7HPjbXy

IF3v5jSp4. All elected tribal officials are 

encouraged to submit written tribal 

testimony to the contact person and 

mailing address listed below or by email 

at Tribalsupport@cdc.gov. 

FOR FURTHER INFORMATION CONTACT: 

Captain Karen Hearod, MSW, LCSW, 

Director, Office of Tribal Affairs and 

Strategic Alliances, Center for State, 

Tribal, Local, and Territorial Support, 

CDC, 1600 Clifton Road NE, Mailstop 

V18–4, Atlanta, GA 30329–4027; 

Telephone: (404) 498–0300; Email: 

Tribalsupport@cdc.gov. 

SUPPLEMENTARY INFORMATION: This 

meeting is being held in accordance 

with Presidential Executive Order No. 

13175, November 6, 2000, and the 

Presidential Memorandum of November 

5, 2009, and September 23, 2004, 

Consultation and Coordination with 

Indian Tribal Governments. 

Purpose: The purpose of the 

consultation meeting is to advance CDC/ 

ATSDR support for and collaboration 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices 35299 

with AI/AN tribal nations and to 

improve the health of AI/AN tribal 

nations by pursuing goals that include 

assisting in eliminating the health 

disparities faced by AI/AN tribal 

nations; ensuring that access to critical 

health and human services and public 

health services is maximized to advance 

or enhance the social, physical, and 

economic status of AI/AN people; and 

promoting health equity for all Indian 

people and communities. To advance 

these goals, CDC/ATSDR conducts 

government-to-government 

consultations with elected tribal 

officials or their authorized 

representatives. Consultation is an 

enhanced form of communication that 

emphasizes trust, respect, and shared 

responsibility. It is an open and free 

exchange of information and opinion 

among parties that leads to mutual 

understanding. 

Matters To Be Considered: CDC/ 

ATSDR is hosting this meeting to hold 

a consultation with federally recognized 

tribal nations to receive input and 

guidance on improving the current 

CDC/ATSDR Tribal Consultation Policy. 

CDC/ATSDR is seeking feedback on 

how the agency can improve its policies 

and practices to better engage with 

Indian Country through meaningful 

consultation. This feedback will be used 

to edit the current CDC’s Consultation 

Policy. The Tribal consultation session 

will provide opportunities for elected 

AI/AN tribal officials to speak openly 

about the public health issues affecting 

their tribal nations. This consultation 

session is virtual and open to the public. 

Elected tribal officials can find guidance 

to assist in developing tribal testimony 

for CDC/ATSDR at https://www.cdc.gov/ 

tribal/documents/consultation/TribalTestimony-Guidance.pdf. Please submit 

tribal testimony on official tribal 

letterhead. 

Based on the number of elected tribal 

officials giving testimony and the time 

available, it may be necessary to limit 

the time for each presenter. We will 

adjourn tribal consultation meetings 

early if all attendees who requested to 

provide oral testimony in advance of 

and during the consultation have 

delivered their comments. Agenda items 

are subject to change as priorities 

dictate. 

Additional information about CDC/ 

ATSDR’s Tribal Consultation Policy can 

be found at https://www.cdc.gov/tribal/ 

consultation-support/tribalconsultation/policy.html. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–14205 Filed 7–1–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2021–0034] 

Advisory Committee on Immunization 

Practices (ACIP); Amended Notice of 

Meeting 

Notice is hereby given of a change in 

the meeting of the Advisory Committee 

on Immunization Practices (ACIP); June 

23, 2021, from 10:00 a.m. to 5:00 p.m., 

EDT (times subject to change); June 24, 

2021, from 10:30 a.m. to 5:10 p.m., EDT 

(times subject to change); and June 25, 

2021, from 10:00 a.m. to 12:20 p.m., 

EDT (times subject to change), in the 

amended FRN. The virtual meeting was 

published in the Federal Register on 

Wednesday, June 23, 2021, Volume 86, 

Number 118, pages 32933–32934. 

The virtual meeting is being amended 

to update the meeting times on June 23– 

25, 2021 (times subject to change) and 

matters to be considered and should 

read as follows: 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC), announces the 

following meeting of the Advisory 

Committee on Immunization Practices 

(ACIP). This meeting is open to the 

public. Time will be available for public 

comment. The meeting will be webcast 

live via the World Wide Web; for more 

information on ACIP please visit the 

ACIP website: http://www.cdc.gov/ 

vaccines/acip/index.html. 

DATES: The meeting will be held on June 

23, 2021, from 11:00 a.m. to 4:00 p.m., 

EDT (times subject to change); June 24, 

2021, from 10:00 a.m. to 5:15 p.m., EDT 

(times subject to change); and June 25, 

2021, from 10:00 a.m. to 1:00 p.m., EDT 

(times subject to change). Written 

comments must be received on or before 

June 25, 2021. 

A notice of this ACIP meeting has also 

been posted on CDC’s ACIP website at: 

http://www.cdc.gov/vaccines/acip/ 

index.html. In addition, CDC has sent 

notice of this ACIP meeting by email to 

those who subscribe to receive email 

updates about ACIP. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Thomas, ACIP Committee 

Management Specialist, Centers for 

Disease Control and Prevention, 

National Center for Immunization and 

Respiratory Diseases, 1600 Clifton Road 

NE, MS–H24–8, Atlanta, GA 30329– 

4027; Telephone: 404–639–8367; Email: 

ACIP@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The committee is charged 

with advising the Director, CDC, on the 

use of immunizing agents. In addition, 

under 42 U.S.C. 1396s, the committee is 

mandated to establish and periodically 

review and, as appropriate, revise the 

list of vaccines for administration to 

vaccine-eligible children through the 

Vaccines for Children (VFC) program, 

along with schedules regarding dosing 

interval, dosage, and contraindications 

to administration of vaccines. Further, 

under provisions of the Affordable Care 

Act, section 2713 of the Public Health 

Service Act, immunization 

recommendations of the ACIP that have 

been approved by the Director of the 

Centers for Disease Control and 

Prevention and appear on CDC 

immunization schedules must be 

covered by applicable health plans. 

Matters To Be Considered: The agenda 

will include discussions on COVID–19, 

dengue vaccine, herpes zoster vaccines, 

influenza vaccines, pneumococcal 

vaccine, and rabies vaccine. 

Recommendation votes on dengue 

vaccine, influenza vaccines and rabies 

vaccine are scheduled. Vaccines for 

Children (VFC) votes on dengue vaccine 

and influenza vaccines are scheduled. 

Agenda items are subject to change as 

priorities dictate. For more information 

on the meeting agenda visit https://

www.cdc.gov/vaccines/acip/meetings/ 

meetings-info.html. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–14203 Filed 7–1–21; 8:45 am] 

BILLING CODE 4163–18–P 


lotter on DSK11XQN23PROD with NOTICES1